ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1010

Total Cost Risk Scores and Barrier Categories in Patients with Axial Spondyloarthritis and Associated Factors

Marina Magrey1, Yashashvi Raghuwanshi2, Tyler Barnett2, lindsay Frumker3 and Omer Pamuk4, 1Case Western Reserve University School of Medicine/University Hospitals, Richfield, OH, 2University hospitals, Cleveland, OH, 3University Hospitals Cleveland, cleveland, OH, 4University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH

Meeting: ACR Convergence 2024

Keywords: Back pain, socioeconomic factors, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Axial spondyloarthritis (axSpA) is associated with an increased risk of morbidity and mortality. Patients with axSpA suffer from chronic back pain, and epidemiological studies reveal poor health and functioning in axial SpA patients.

Methods: Clinical and demographic features of patients with a diagnosis of ankylosing spondylitis (M45.9) or inflammatory spondylopathy (M46.99) seen by a rheumatologist at our institution between 2021 and 2024 were extracted using SlicerDicer within the EPIC EHR. Controls included subjects with chronic low back pain (M54.5) evaluated by a rheumatologist with no axSpA diagnosis. HLA-B27 positive Patients that fulfilled the clinical arm of 2009 ASAS classification criteria were included and controls with chronic low back pain.
TCRS and BC data were sourced from the Lexis Nexis / SDOH database. TCRS system comprises various sections that assess the socioeconomic factors and risk levels associated with members/patients. Sections of TCRS are shown in Figure 1A. The scoring system determines the mean TCRS, socioeconomic ranking (0-100), and socioeconomic category classes (ranging from extremely high to very low-risk percentiles).
The BC, formerly known as the Motivation category; encompasses various sections that evaluate individuals’ predicted motivation levels and their commitment to self-health management. Sections of BC are shown in Figure 1B. Moreover, the BC is associated with five risk levels: extremely high, high, medium, low, and very low.
For statistical analysis, chi-square, unpaired t, and Mann-Whitney U tests were utilized.

Results: 91 patients with axSpA and 117 controls were included. The mean age of axSpA was significantly younger than that of controls (p < 0.001). The frequency of female patients tended to be lower in axial SpA group (p = 0.055). The median TCRS index score was significantly lower in axial SpA patients than controls (p = 0.0012). Additionally, the frequency of the extremely high/high-risk socioeconomic category was significantly lower in axial SpA patients compared to controls (23.1% vs. 41%, p = 0.0064) (Table 1). Moreover, the frequency of extremely high/high-risk BC categories was significantly higher in the axSpA group than controls (18.7% vs. 7.7%, p = 0.0017). The median BC score was lower in patients with axial SpA, but this difference was insignificant (p = 0.069). 
In the axial SpA group, TCRS scores and socioeconomic risk categories did not differ between male and female patients. However, the mean BC score was significantly higher in female axial SpA patients than in males (51.5 ± 10.9 vs. 31.4 ± 18.7, p < 0.0001). High-risk BC categories were significantly less frequent in female axial SpA patients (3.4% vs. 88.2%, p < 0.0001).

Conclusion: Our study demonstrated that socioeconomic categories and motivation for health were better in axial SpA patients compared to controls. Although there was no difference in TCRS between female and male axial SpA groups, motivation for health was significantly higher in female axSpA patients.

Supporting image 1

FIG 1A- Total cost score

Supporting image 2

FIG_1B Motivational score

Supporting image 3

Table 1 -Demographics, Clinical characteristics and scores of axial SpA patients and controls


Disclosures: M. Magrey: AbbVie, 2, 5, BMS, 2, 5, Eli Lilly, 2, Novartis, 2, Pfizer, 2, UCB Pharma, 2, 5; Y. Raghuwanshi: None; T. Barnett: None; l. Frumker: None; O. Pamuk: None.

To cite this abstract in AMA style:

Magrey M, Raghuwanshi Y, Barnett T, Frumker l, Pamuk O. Total Cost Risk Scores and Barrier Categories in Patients with Axial Spondyloarthritis and Associated Factors [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/total-cost-risk-scores-and-barrier-categories-in-patients-with-axial-spondyloarthritis-and-associated-factors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/total-cost-risk-scores-and-barrier-categories-in-patients-with-axial-spondyloarthritis-and-associated-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology